Journal of Medical Microbiology · 2013 · 33 citations · 51 references
Life SciencesMicrobiologyMolecular GeneticsAntimicrobial ResistanceMedical MicrobiologyMicrobial GeneticsAntibiotic ResistanceBacterial EpidemiologyBacterial PathogenesisBacterial Virulence FactorsMicrobial Virulence FactorsPathogenicity IslandsCommunity-acquired Methicillin-resistant Staphylococcus Aureus InfectionGenetic Diversity DynamicsGenomic Island DetectionGenomic Island EvolutionResistance Mechanisms In StaphylococciStaphylococcal Skin InfectionStaphylococcus Aureus ColonizationVirulence Factor Epidemiology
Panton-Valentine leukocidine (PVL) is a distinctive virulence factor of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), and arginine catabolic mobile element (ACME) is a staphylococcal genomic island that enhances fitness and the ability of bacterial cells to colonize on skin and mucous membranes. ACME is characteristically found in USA300, which is a predominant CA-MRSA clone [sequence type (ST) 8] in the USA and is spreading globally, and has also been detected in non-ST8 MRSA at low frequency. In Japan, spread of MRSA with PVL and/or ACME and their genetic traits have not yet been well characterized. In the present study, the prevalence and genetic diversity of PVL(+)/ACME(+) MRSA were investigated for 422 MRSA clinical isolates collected from outpatients in northern Japan over a period of 1 year. All the isolates were genotyped for the staphylococcal cassette chromosome mec (SCCmec) and coagulase genes (coa), and screened for PVL and ACME genes. The PVL(+)/ACME(+) isolates were studied further by genetic analysis, including single-nucleotide polymorphism (SNP) analysis based on PVL genes (lukS-PV-lukF-PV), ACME (arc and opp3 clusters) and the sarU promoter region. Among all the isolates examined, PVL genes and ACME were detected in eight (SCCmec-II, n = 1; SCCmec-IV, n = 6; SCCmec-V, n = 1) and 20 (SCCmec-II, n = 14; SCCmec-IV, n = 5; SCCmec-V, n = 1) isolates, respectively. Five isolates were found to have both PVL genes and ACME (type I), and were classified into ST8/spa-t008/agr-I/coa-IIIa, which is the same genetic traits as USA300. Fifteen PVL(-)/ACME(+) isolates had type ΔII-ACME, belonging to either ST5 or ST764 [clonal complex (CC) 5], and spa-t001, -t002 or -t3557. All the ST8 PVL(+)/ACME-I(+) MRSA had identical sequences of PVL genes (haplotype R) and ACME arc/opp3 clusters as those of USA300. In contrast, in the CC5 PVL(-)/ACME-ΔII(+) MRSA, SNPs in the arc cluster were detected in 11 sites (four haplotypes), with some different profiles of virulence/resistance factors. These results indicated single clonality of ST8 PVL(+)/ACME-I(+) MRSA and heterogeneity of CC5 PVL(-)/ACME-ΔII(+) MRSA, and suggest their potential spread in northern Japan.
51
Mark C. Enright, Nicholas Day, Catrin E. Davies et al. · Journal of Clinical Microbiology · 2000 · 3K citations · Full text
François Vandenesch, Timothy S. Naimi, Mark C. Enright et al. · Emerging infectious diseases · 2003 · 1.7K citations · Full text
Genome and virulence determinants of high virulence community-acquired MRSA
Tadashi Baba, Fumihiko Takeuchi, Makoto Kuroda et al. · The Lancet · 2002 · 1.4K citations
Yoko Kondo, Teruyo Ito, Xiao Xue et al. · Antimicrobial Agents and Chemotherapy · 2006 · 966 citations · Full text